| Expression pattern: |
UP |
| Associated gene: |
ALYREF, FASN, SKP2 |
| Associated microRNA: |
miR-124 |
| Biological function: |
promotes proliferation, migration, invasion and angiogenesis; inhibits apoptosis; promotes tumor growth in vivo |
| Molecular mechanism: |
circHIPK3 binds ALYREF, inhibits ubiquitination-mediated degradation of ALYREF, thereby stabilizing FASN mRNA |
| Biological pathway or process: |
angiogenesis (promotes); apoptosis (inhibits); proliferation (promotes); migration (promotes); invasion (promotes); mRNA stability (promotes) |
| Detected method: |
Q
|
| Validation methods: |
RT-qPCR; RNase R Treatment; Actinomycin D / DRB Stability Assay; FISH / smFISH; Nuclear-Cytoplasmic Fractionation; RNA Pull-Down; RIP (RNA Immunoprecipitation); Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Transwell Assay; Tube Formation Assay; Western Blot; Co-IP; In Vivo Animal Model; IHC (Immunohistochemistry); Bioinformatics Analysis; Clinical Sample Validation |
| Clinical significance: |
Elevated circHIPK3 expression correlates with TNM stages and lymph node metastasis; proposed as a prognostic biomarker and therapeutic target |
| Description: |
circHIPK3 is up-regulated in gallbladder cancer and promotes malignant phenotypes (proliferation, migration/invasion, angiogenesis) while inhibiting apoptosis. Mechanistically, it binds and stabilizes the RBP ALYREF by reducing its ubiquitination, which in turn stabilizes FASN mRNA and increases FASN expression, driving angiogenesis and anti-apoptotic effects. |
| Confidence score: |
0.8635 |